ICA Group Wealth Management »

Inozyme Pharma shares owned by ICA Group Wealth Management

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by ICA Group Wealth Management from 13F filings

Historical chart of ICA Group Wealth Management investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by ICA Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by ICA Group Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $650 85 7.66

More positions owned by ICA Group Wealth Management

Invesco Qqq MF Closed and MF Open (QQQ)
SPDR S&P MF Closed and MF Open (SPY)
JP Morgan Core Plus Bond ETF Stock/ETF (JCPB)
First Trust MF Closed and MF Open (FDL)
Apple Common Stock (AAPL)
Vanguard Russell 1000 Growth Stock/ETF (VONG)
JPMorgan Equity Premium Income ETF Stock/ETF (JEPI)
First Trust MF Closed and MF Open (FVD)
SPDR S&P MF Closed and MF Open (VLU)
Vanguard Value MF Closed and MF Open (VTV)
Invesco S&p MF Closed and MF Open (XMHQ)
Ishares Core MF Closed and MF Open (IVV)
iShares Treasury Floating Rate Bond Stock/ETF (TFLO)
iShares MSCI World Index Stock/ETF (URTH)
Nvidia Corp Common Stock (NVDA)

View all positions for ICA Group Wealth Management

Top funds holding Inozyme Pharma

Adage Capital Partners GP
Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
Samlyn Capital
BlackRock
Affinity Asset Advisors
Vanguard Group
NEA Management Company
FMR
Millennium Management
Samsara BioCapital
Sphera Funds Management
Geode Capital Management

View all funds holding Inozyme Pharma